Pulmonx (Lung) 2025 Earnings Outlook for Investors
Pulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...
An introductory note on why early financial planning matters for young adults, with initial steps to start building a solid plan.
23,781 articlesPulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...
AI is changing how brands manage social media, and Sprout Social sits at the intersection of engagement, analytics, a...
Even as oil prices swing widely, four energy dividend giants have kept their payouts steady and growing. This piece l...
A single day shows $31.6m ethereum leaves exchanges, pushing reserves to multi-year lows and reigniting bets on a pot...
The weight loss field is heating up, with Novo Nordisk leading the GLP-1 wave and Amgen pursuing a smaller, more sele...
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
February data show a 9% month-over-month rise in rate-lock volume as lower borrowing costs draw buyers back. Purchase...
Three utility ETFs are posting eye-catching gains as data-center demand grows, underscoring a new growth era for the ...
A mid-2026 pullback in amazon stock pulled back has investors weighing growth ambitions against profitability. This g...
KeyBanc maintains an overweight stance on AeroVironment after Q3 results, signaling the stock could benefit from esca...
A new wave of questions surrounds a16z exec steven sinofsky as reports tie him to Epstein during his Microsoft exit. ...
As tariffs re-emerge under Section 301, policymakers push a framework that has endured decades of legal challenges. T...